Evidence map›Paper›PMID 24367491›Full record

ArticlePloS one2013

Novel microarrays for simultaneous serodiagnosis of multiple antiviral antibodies.

Ponnurengam Malliappan Sivakumar, Nozomi Moritsugu, Sei Obuse, Takashi Isoshima, Hideo Tashiro, Yoshihiro Ito

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Rapid and quantitative detection of multiple antibodies against SARS-CoV-2 mutant proteins by photo-immobilized microarray.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ponnurengam Malliappan SivakumarNano Medical Engineering Laboratory, RIKEN, Wako, Saitama, Japan.
Nozomi MoritsuguNano Medical Engineering Laboratory, RIKEN, Wako, Saitama, Japan.
Sei ObuseNano Medical Engineering Laboratory, RIKEN, Wako, Saitama, Japan.
Takashi IsoshimaNano Medical Engineering Laboratory, RIKEN, Wako, Saitama, Japan.
Hideo TashiroNano Medical Engineering Laboratory, RIKEN, Wako, Saitama, Japan ; Consonal Biotechnologies Co., Ltd., Funabashi, Chiba, Japan.
Yoshihiro ItoNano Medical Engineering Laboratory, RIKEN, Wako, Saitama, Japan ; Consonal Biotechnologies Co., Ltd., Funabashi, Chiba, Japan ; Emergent Bioengineering Materials Research Team, RIKEN Center for Emergent Matter Science, Wako, Saitama, Japan.
RIKEN · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed an automated diagnostic system for the detection of virus-specific immunoglobulin Gs (IgGs) that was based on a microarray platform. We compared efficacies of our automated system with conventional enzyme immunoassays (EIAs). Viruses were immobilized to microarrays using a radical cross-linking reaction that was induced by photo-irradiation. A new photoreactive polymer containing perfluorophenyl azide (PFPA) and poly(ethylene glycol) methacrylate was prepared and coated on plates. Inactivated measles, rubella, mumps, Varicella-Zoster and recombinant Epstein-Barr viruse antigen were added to coated plates, and irradiated with ultraviolet light to facilitate immobilization. Virus-specific IgGs in healthy human sera were assayed using these prepared microarrays and the results obtained compared with those from conventional EIAs. We observed high correlation (0.79-0.96) in the results between the automated microarray technique and EIAs. The microarray-based assay was more rapid, involved less reagents and sample, and was easier to conduct compared with conventional EIA techniques. The automated microarray system was further improved by introducing reagent storage reservoirs inside the chamber, thereby conserving the use of expensive reagents and antibodies. We considered the microarray format to be suitable for rapid and multiple serological diagnoses of viral diseases that could be developed further for clinical applications.

Indexed as

Oligonucleotide Array Sequence AnalysisAntibodies, ViralAzidesHerpesvirus 4, HumanHumansHydrocarbons, FluorinatedImmunoenzyme TechniquesImmunoglobulin GMumps virusRubella virusSerologic TestsAntibodies, ViralAzidesHydrocarbons, FluorinatedImmunoglobulin Gperfluorophenyl azide

Identifiers

PMID24367491
PMCPMC3867344
OpenAlexW1991550449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.